About the Authors

Cassandra Coburn, Alexandre Benedetto, Filipe Cabreiro, Caroline Araiz, Abraham Mandel, Sally-Anne Edwards, Grahame Fischer, Alexander Davidson, Rosina E. Pryor, Ailsa Stevens, David Gems
Institute of Healthy Ageing, and Research Department of Genetics, Evolution and Environment, University College London, London, United Kingdom

Erik Allman, Keith Nehrke
Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York, United States of America

Parag Mahanti, Frank C. Schroeder
Boyce Thompson Institute and Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York, United States of America

Zachary Pincus, Frank J. Slack
Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut, United States of America

Filip Matthijssens, Bart P. Braeckman
Department of Biology, Ghent University, Ghent, Belgium

Manolis Vlachos, Nektarios Tavernarakis
Institute of Molecular Biology and Biotechnology, University of Crete, Heraklion, Crete, Greece

Keith Nehrke
Department of Medicine, University of Rochester Medical Center, Rochester, New York, United States of America

Corresponding Author

david.gems@ucl.ac.uk

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: CC DG KN PM AB FC. Performed the experiments: CC AD SAE AS FS ZP PM BB FM AM GF EA KN MV NT AB CA FC REP. Analyzed the data: CC DG KN EA PM FS BB FM MV NT AB. Contributed reagents/materials/analysis tools: PM FS EA FJS KN FM BB. Wrote the paper: CC DG KN. AS worked as an undergraduate project student to identify the severity of different Glo mutant phenotypes, consequently allowing us to select glo-1(zu347) as the primary mutant of study.